Table 1 Baseline characteristics of type 2 diabetes mellitus (T2DM) patients divided according to the cardiovascular death
Variable | Non-survivors (n = 16) | Survivors (n = 117) | p-value |
|---|---|---|---|
Age, years | 70.5 (64.0–77.0) | 65.0 (60.0–71.0) | 0.09 |
Female gender, n (%) | 5 (31.3) | 49 (41.9) | 0.59 |
Current smoking, n (%) | 2 (12.5) | 10 (8.6) | 0.64 |
Body-mass index, kg/m2 | 31.4 (26.2–34.2) | 31.6 (28.4–35.4) | 0.34 |
Obesity, n (%) | 10 (62.5) | 80 (68.4) | 0.78 |
Time since T2DM diagnosis, years | 8.0 (2.0–13.0) | 5.0 (2.0–10.0) | 0.43 |
Comorbidities, n (%) | |||
Arterial hypertension | 14 (87.5) | 112 (95.7) | 0.20 |
Coronary artery disease | 13 (62.3) | 73 (62.4) | 0.17 |
Previous myocardial infarction | 6 (37.5) | 19 (16.2) | 0.08 |
Previous stroke | 3 (18.8) | 4 (3.4) | 0.04 |
Nephropathy | 6 (37.5) | 17 (14.5) | 0.03 |
Neuropathy | 4 (25.0) | 20 (17.1) | 0.49 |
Retinopathy | 4 (25.0) | 17 (14.5) | 0.28 |
Medications, n (%) | |||
Acetylsalicylic acid | 13 (81.3) | 92 (78.6) | 1.00 |
Statin | 13 (81.3) | 93 (79.5) | 1.00 |
ACE-I | 10 (62.5) | 81 (69.2) | 0.58 |
β-blocker | 14 (87.5) | 91 (77.8) | 0.52 |
Metformin | 5 (31.3) | 75 (64.1) | 0.02 |
Sulfonylourea | 9 (56.3) | 47 (40.2) | 0.28 |
Insulin | 6 (37.5) | 27 (23.1) | 0.23 |